Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
PANews reported on May 12 that bitcoin mining company MARA released its first-quarter financial report, showing that revenue fell 18% year-on-year to $174.6 million, and net loss widened to $1.3 billion, mainly due to unrealized losses from its 38,689 bitcoin on the balance sheet.

PANews reported on May 12 that bitcoin mining company MARA released its first-quarter financial report, showing that revenue fell 18% year-on-year to $174.6 million, and net loss widened to $1.3 billion, mainly due to unrealized losses from its 38,689 bitcoin on the balance sheet.

老虎证券老虎证券2026/05/12 06:14
Show original
Bitcoin mining remains the company’s “operational foundation,” and it plans to colocate new infrastructure with its existing mining business, maintaining the option to redirect power toward AI and high-performance computing while generating mining income. MARA stated it does not intend to make large-scale purchases of ASIC miners in the future and will remain selective and targeted. In Q1, the company mined 2,247 Bitcoins, and its hash rate grew by 33% year-on-year to 72.2 EH/s. Near the end of the quarter, the company sold about $1.1 billion worth of Bitcoin to repay debt and increase financial flexibility, dropping its exchange ranking to fourth place. After the financial report was released, MARA’s stock price fell by more than 5% in after-hours trading.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Why did the Reserve Bank of Australia raise interest rates two weeks ago? Meeting minutes reveal inflation risks have become a reality, and waiting would be too costly

The Reserve Bank of Australia acknowledges that the trade-off between inflation and full employment has worsened, but maintains that its goal is to return the Consumer Price Index (CPI) to the 2-3% target range.

智通财经•2026/10/13 02:41

Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results

Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.

智通财经•2026/10/13 01:56